Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial) von Lee, Keun-Wook, Chung, Ik-Joo, Ryu, Min-Hee, Park, Young Iee, Nam, Byung-Ho, Oh, Ho-Suk, Lee, Kyung Hee, Han, Hye Sook, Seo, Bong-Gun, Jo, Jae-Cheol, Lee, Hyo Rak, Kim, Jin Won, Park, Sook Ryun, Cho, Sang Hee, Kang, Yoon-Koo

Volltext

Simvastatin plus capecitabine–cisplatin versus placebo plus capecitabine–cisplatin in patients with previously untreated advanced gastric cancer: A double-blind randomised phase 3... von Kim, Seung Tae, Kang, Jung Hun, Lee, Jeeyun, Park, Se Hoon, Park, Joon Oh, Park, Young Suk, Lim, Ho Yeong, Hwang, In Gyu, Lee, Sang-Cheol, Park, Keon-Woo, Lee, Hyo Rak, Kang, Won Ki

Volltext

Secondary hematological malignancies in patients with sarcoma: A single‑center retrospective study von Jang, Yoon Jung, Jeong, Hong Kyu, Kong, Chang-Bae, Song, Won Seok, Cho, Wan Hyeong, Jeon, Dae Geun, Kim, Heyjin, Yang, Sung Hyun, Na, Im Il, Lee, Hyo-Rak, Kang, Hye Jin

Volltext

A Phase II Study of I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma von Yoon Jung Jang, Sang Moo Lim, Inki Lee, Byung Hyun Byun, Ilhan Lim, Byung Il Kim, Chang Woon Choi, Seung-Sook Lee, Sung Hyun Yang, Im Il Na, Hyo-Rak Lee, Dong-Yeop Shin, Hye Jin Kang

Volltext

Radioimmunotherapy with 131I‐rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma von Yoon Jung Jang, Lim, Sang Moo, Lee, Inki, Byun, Byung Hyun, Lim, Ilhan, Byung Il Kim, Choi, Chang Woon, Seung‐Sook Lee, Suh, Cheolwon, Yoon, Dok Hyun, Kim, Inho, Seung‐Hyun Nam, Mark Hong Lee, Jong Ho Won, Kong, Jee Hyun, Jeong, Seong Hyun, Oh, Suk Joong, Keon Woo Park, Han, Jae Joon, Moo‐Kon Song, Yang, Sung Hyun, Im, Il Na, Hyo‐Rak Lee, Dong‐Yeop Shin, Hye Jin Kang

Volltext

Radioimmunotherapy with 131 I-rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma von Jang, Yoon Jung, Lim, Sang Moo, Lee, Inki, Byun, Byung Hyun, Lim, Ilhan, Kim, Byung Il, Choi, Chang Woon, Lee, Seung-Sook, Suh, Cheolwon, Yoon, Dok Hyun, Kim, Inho, Nam, Seung-Hyun, Lee, Mark Hong, Won, Jong Ho, Kong, Jee Hyun, Jeong, Seong Hyun, Oh, Suk Joong, Park, Keon Woo, Han, Jae Joon, Song, Moo-Kon, Yang, Sung Hyun, Na, Im Il, Lee, Hyo-Rak, Shin, Dong-Yeop, Kang, Hye Jin

Volltext

Prevalent factor XII deficiency in cancer patients with isolated aPTT prolongation von Shin, Dong-Yeop, Lee, Hyo-Rak, Kang, Hye Jin, Na, Im Il, Chang, Yoon Hwan, Yang, Sung Hyun

Volltext

Association of EGFR mutations in second primary lung cancer and HER2 expression in breast cancer survivors von Jang, Yoon Jung, Kim, Seo Yun, Jung, Hong Kyu, Kim, Hye-Ryoun, Kim, Cheol Hyeon, Lee, Hyo-Rak, Kang, Hye Jin, Yang, Sung Hyun, Seol, Hyesil, Na, Im Il

Volltext

Visceral adipose tissue is prognostic for survival of diffuse large B cell lymphoma treated with frontline R-CHOP von Shin, Dong-Yeop, Kim, Areumnuri, Byun, Byung Hyun, Moon, Hansol, Kim, Soyeun, Ko, Young-Jin, Kim, Min-Jung, Lee, Hyo-Rak, Kang, Hye-Jin, Na, Im Il, Park, Sunhoo, Lee, Seung Sook, Yang, Sung-Hyun

Volltext

A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma von PARK, Byeong-Bae, JOON OH PARK, YOUNG SUK PARK, LIM, Ho-Yeong, WON KI KANG, PARK, Keunchil, HYO RAK LEE, LEE, Jeeyun, DONG WOOK CHOI, CHOI, Seong-Ho, JIN SEOK HEO, JONG KYUN LEE, KYU TAEK LEE, DO HOON LIM

Volltext

A phase II trial of modified FOLFOX6 as first-line therapy for adenocarcinoma of an unknown primary site von Shin, Dong-Yeop, Choi, Yoon Hee, Lee, Hyo-Rak, Na, Im Il, Yuh, Young Jin, Kim, Bong-Seog, Chung, Ik Joo, Bae, Woo-Kyun, Shim, Hyun-Jeong, Song, Eun-Kee, Yang, Sung Hyun, Kang, Hye Jin

Volltext

Attenuated FOLFIRINOX in the salvage treatment of gemcitabine‐refractory advanced pancreatic cancer: a phase II study von Kim, Jung Hoon, Lee, Sang‐Cheol, Oh, Sung Yong, Song, Seo‐Young, Lee, Namsu, Nam, Eun Mi, Lee, Soonil, Hwang, In Gyu, Lee, Hyo Rak, Lee, Kyu Taek, Bae, Sang‐Byung, Kim, Han Jo, Jang, Joung Soon, Lim, Do Hyoung, Lee, Hyun Woo, Kang, Seok Yun, Kang, Jung Hun

Volltext

Cytogenetic biodosimetry for Fukushima travelers after the nuclear power plant accident: no evidence of enhanced yield of dicentrics von Lee, Jin Kyung, Han, Eun-Ae, Lee, Seung-Sook, Ha, Wi-Ho, Barquinero, Joan Francesc, Lee, Hyo Rak, Cho, Min Su

Volltext

A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma von Lee, Jeeyun, Im, Young-Hyuck, Cho, Eun Yoon, Hong, Yong Sang, Lee, Hyo Rak, Kim, Hyo Song, Kim, Mi-Jin, Kim, Kwhanmien, Kang, Won Ki, Park, Keunchil, Shim, Young Mog

Volltext

Postremission therapy for acute myeloid leukemia in the first remission von Kim, Seung Tai, Jung, Chul Won, Lee, Jeeyun, Kwon, Jung Mi, Oh, Sung Young, Park, Byeong-Bae, Lee, Hyo Rak, Kim, Hyun Jung, Kim, Kihyun, Kim, Won Seog, Ahn, Jin Seok, Kang, Won Ki, Park, Keunchil

Volltext

Chromosome aberration dynamics in breast cancer patients treated with radiotherapy: Implications for radiation biodosimetry von Lee, Younghyun, Kang, Jin-Kyu, Lee, Yang Hee, Yoon, Hyo Jin, Yang, Su San, Kim, Seung Hyun, Jang, Seongjae, Park, Sunhoo, Heo, Da Hye, Jang, Won Il, Yoo, Hyung Jun, Paik, Eun Kyung, Lee, Hyo Rak, Seong, Ki Moon

Volltext

Therapy-related myeloid neoplasms in Korean patients with ovarian or primary peritoneal cancer treated with poly(ADP-ribose) polymerase inhibitors von Jang, Yoon Jung, Kim, Heyjin, Ryu, Sang-Young, Kim, Moon-Hong, Kim, Beob-Jong, Jung, Hee Jung, Kang, Jisik, Yang, Sung Hyun, Na, Im Il, Lee, Hyo-Rak, Kang, Hye Jin

Volltext

Oxaliplatin and UFT combination chemotherapy in patients with metastatic colorectal cancer von KIM, Kihyun, NAM, Eunmi, JOON OH PARK, WON SEOG KIM, CHUL WON JUNG, IM, Young-Hyuk, LEE, Mark H, WOO YONG LEE, CHUN, Hokyung, PARK, Chan H, PARK, Keunchil, WON KI KANG, NAM SOO LEE, HYE RAN LEE, JEE YUN LEE, HYO RAK LEE, SE HOON PARK, SUNG YONG OH, JI HYANG KIM, SEO YOUNG SONG

Volltext

A Phase II Study of 131 I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma von Jang, Yoon Jung, Lim, Sang Moo, Lee, Inki, Byun, Byung Hyun, Lim, Ilhan, Kim, Byung Il, Choi, Chang Woon, Lee, Seung-Sook, Yang, Sung Hyun, Na, Im Il, Lee, Hyo-Rak, Shin, Dong-Yeop, Kang, Hye Jin

Volltext

A Phase II Study of 131I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma von Jang, Yoon Jung, Lim, Sang Moo, Lee, Inki, Byun, Byung Hyun, Lim, Ilhan, Kim, Byung Il, Choi, Chang Woon, Lee, Seung-Sook, Yang, Sung Hyun, Na, Im Il, Lee, Hyo-Rak, Shin, Dong-Yeop, Kang, Hye Jin

Volltext